Search

The International Society of Viruses of Microorganisms (ISVM) is calling for applications to organize the Viruses of Microbes (VoM) 2026 conference. Interested ISVM members should submit their applications by April 30, 2024, to board@isvm.

Only 4 months remain until the Viruses of Microbes 2024 Meeting takes place (July 15-19, 2024). Phage researchers are encouraged to confirm their participation early to plan for the trip down under!

The International Society of Microbiota will host their 11th Annual Meeting, Targeting Microbiota, on October 17-18 at the Corinthia Palace Malta, to explore the role of microbiota in health and disease, advancements in microbiome medicine,

Cytophage partnered with Dr. Marisa Azad at The Ottawa Hospital to deliver the first phage therapy in Canada for a patient with a severe hardware-associated joint infection. The phage treatment was produced by Cytophage, targeted Staphyloco

Intralytix has received Safe Quality Food (SQF) certification for food manufacturing, becoming the only phage company to attain such recognition.

Pramalkumar Patel (University of Toronto) and colleagues uncovered a novel anti-phage defence mechanism, where the P. aeruginosa prophage protein Tab blocks phage tail assembly, preventing formation of infectious virions.

Ryan Cook (Quadram Institute) and colleagues published a paper on benchmarking viromics using Illumina, Nanopore and PacBio. They constructed a mock phage community and used it to compare effectiveness of different sequencing technologies.

Jose L Figueroa (North Carolina Research Center) and colleagues published a new tool, MetaCerberus, a massively parallel, fast, low memory, scalable annotation tool for gene function inference across the tree of life (including phages!). Th

Wondering how phage therapy startups raise money? PhageLab recently raised $11M, and this ‘pitch deck teardown’ blog post goes through the pitch deck they used to convince investors, which slides pack the most punch, and other tips.

The International Society of Viruses of Microorganisms (ISVM) is calling for applications to organize the Viruses of Microbes (VoM) 2026 conference. Interested ISVM members should submit their applications by April 30, 2024, to board@isvm.

The 2nd Symposium of the Belgian Society for Viruses of Microbes (BSVoM) was held on September 8, 2023, at the University of Liège, featuring over 140 researchers from 10 countries discussing phage ecology, diversity, and applications. The

The BV-BRC Viral Sub-species Classification Workshop, funded by NIAID, will be held in Rockville, MD from April 8-10, 2024. This hybrid event, in collaboration with the CDC and NCBI, aims to establish best practices for viral sub-species c

Precisio Biotix Therapeutics has acquired London-based CC Bio. This gives Precisio access to CC Bio's ZEUS lysin platform, a bioinformatics platform highly complementary to Precisio's high-throughput screening, engineering, and AI system fo

PrecisionPhage, a new startup based in Finland, has launched Phagenomics, a browser-based tool for phage genome analysis to streamline assembly and annotation for researchers and clinicians.

Milan Gerovac (University of Würzburg) and colleagues published a new paper revealing how phage-encoded proteins, particularly from jumbo phage ΦKZ, target and co-opt P. aeruginosa ribosomes immediately after infection. They make the case t

The CDC has launched an Antimicrobial Resistance Investment Map (interestingly, they are calling it ‘AR’ now — is this our new acronym for AMR?). The map illustrates the allocation of CDC funds in the US and abroad. Explore funding landscap

The ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network is offering funding for Phase II or III clinical trials focusing on antimicrobial agents for multi-resistant Gram-negative bacilli infections. Application deadline

In a recent podcast episode of This Week in Virology (TWiV), learn how a viral capsid protein activates a bacterial innate immune system, interfering with protein synthesis, and human-associated redondoviruses that infect the commensal prot

In another recent TWiV episode, learn how mammalian cells internalize and utilize phage particles to enhance cell growth and survival.

BiomX and Adaptive Phage Therapeutics have announced they will merge! They concurrently announce new financing of $50 million, which will help advance the combined company’s two Phase 2 assets: one for CF and one for diabetic foot ulcers.